Comments on: “Early High-Titer Convalescent Plasma Therapy in Patients with Moderate and Severe COVID-19” [Transfusion and Apheresis Science 61 (2022) 103321]
Dear Editor We wish to draw attention to the recent study by Fazeli et al.,1 which investigates the efficacy of early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19. The authors conclude that this therapy is beneficial for Iranian patients with moderate COVID-19...
Saved in:
Main Author: | Seyed Reza Hosseiniara |
---|---|
Format: | Article |
Language: | English |
Published: |
Sadra Danesh Negar
2024-11-01
|
Series: | Journal of Preventive and Complementary Medicine |
Subjects: | |
Online Access: | https://www.jpcmed.com/article_208338_93aa865d4b7f435436147e0e65007971.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Convalescent plasma therapy in severe coronavirus disease-2019: A narrative review
by: Rasmi Ranjan Sahoo, et al.
Published: (2020-01-01) -
Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series study
by: Marie Didembourg, et al.
Published: (2025-01-01) -
Correlation between Neutrophile to Lymphocyte Ratio and D-dimer with COVID-19 Severity
by: Citra Suhesty, et al.
Published: (2023-09-01) -
Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort
by: Jared Sheehan, et al.
Published: (2025-01-01) -
COVID-19 in patients with severe mental illness: An analysis of in-patients at a psychiatric hospital in Cape Town
by: Haseena B. Sablay, et al.
Published: (2025-01-01)